91 related articles for article (PubMed ID: 8363219)
1. Successful treatment with a novel immunosuppressive agent, deoxyspergualin, in type II collagen-induced arthritis in mice.
Nemoto K; Mae T; Abe F; Takeuchi T
Ann N Y Acad Sci; 1993 Jun; 685():148-54. PubMed ID: 8363219
[No Abstract] [Full Text] [Related]
2. Effects of deoxyspergualin on collagen arthritis in mice.
Takagishi K; Yamamoto M; Maeda K; Nishimura A; Yonemoto K; Hotokebuchi T; Kaibara N
Clin Immunol Immunopathol; 1990 Jul; 56(1):81-7. PubMed ID: 2357860
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
[TBL] [Abstract][Full Text] [Related]
4. Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology.
Rordorf C; Pataki A; Nogues V; Schlager F; Feige U; Glatt M
Int J Tissue React; 1987; 9(4):341-7. PubMed ID: 3623829
[TBL] [Abstract][Full Text] [Related]
5. Effects of FK-506 on collagen arthritis in mice.
Takagishi K; Yamamoto M; Nishimura A; Yamasaki G; Kanazawa N; Hotokebuchi T; Kaibara N
Transplant Proc; 1989 Feb; 21(1 Pt 1):1053-5. PubMed ID: 2468205
[No Abstract] [Full Text] [Related]
6. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody.
Banerjee S; Wei BY; Hillman K; Luthra HS; David CS
J Immunol; 1988 Aug; 141(4):1150-4. PubMed ID: 3135321
[TBL] [Abstract][Full Text] [Related]
8. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
9. [The role of anti-type II collagen antibody in the pathogenesis of murine collagen-induced arthritis].
Hirofuji T; Kakimoto K; Koga T; Saisho K; Sumiyoshi A
Fukuoka Igaku Zasshi; 1986 Mar; 77(3):185-93. PubMed ID: 3721384
[No Abstract] [Full Text] [Related]
10. Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis.
Wolos JA; Frondorf KA; Esser RE
J Immunol; 1993 Jul; 151(1):526-34. PubMed ID: 8326139
[TBL] [Abstract][Full Text] [Related]
11. Immunological unresponsiveness by deoxyspergualin therapy in mice undergoing lethal graft-vs-host disease, and successful adoptive transfer of unresponsiveness.
Nemoto K; Sugawara Y; Mae T; Hayashi M; Abe F; Fujii A; Takeuchi T
Transplant Proc; 1991 Feb; 23(1 Pt 1):862-3. PubMed ID: 1990707
[No Abstract] [Full Text] [Related]
12. Use of a novel immunosuppressive agent, deoxyspergualin, in a case of ABO-incompatible kidney transplantation.
Takahasi K; Ota K; Ooba S; Tanabe K; Fuchinoue S; Honda H; Teraoka S; Toma H; Agishi T; Amemiya H
Clin Transpl; 1989; ():306-7. PubMed ID: 2487584
[No Abstract] [Full Text] [Related]
13. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
Vermeire K; Thielemans L; Matthys P; Billiau A
J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498
[TBL] [Abstract][Full Text] [Related]
14. Stability and immunosuppressive activity of deoxyspergualin in comparison with deoxymethylspergualin.
Fujii H; Takada T; Nemoto K; Abe F; Takeuchi T
Transplant Proc; 1989 Jun; 21(3):3471-3. PubMed ID: 2525828
[No Abstract] [Full Text] [Related]
15. Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted adult mice.
Loughry A; Fairchild S; Athanasou N; Edwards J; Hall FC
Rheumatology (Oxford); 2005 Mar; 44(3):299-308. PubMed ID: 15637034
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibody specific for human type II collagen: possible implication in collagen-induced arthritis.
Hirofuji T; Kakimoto K; Hori H; Nagai Y; Saisho K; Sumiyoshi A; Koga T
Clin Exp Immunol; 1985 Oct; 62(1):159-66. PubMed ID: 2998657
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
[TBL] [Abstract][Full Text] [Related]
18. Extended functional survival of murine islet allografts with 15-deoxyspergualin.
Kaufman DB; Field MJ; Gruber SA; Farney AC; Stephanian E; Gores PF; Sutherland DE
Transplant Proc; 1992 Jun; 24(3):1045-7. PubMed ID: 1604510
[No Abstract] [Full Text] [Related]
19. [Induction of arthritis in mice by injection of homologous type II collagen].
Boissier MC; Roudier R; Carlioz A; Fournier C
C R Acad Sci III; 1986; 302(19):665-8. PubMed ID: 3091203
[TBL] [Abstract][Full Text] [Related]
20. A new immunosuppressive agent, 15-deoxyspergualin, in dog renal allografting.
Amemiya H; Suzuki S; Niiya S; Fukao K; Yamanaka N; Ito J
Transplant Proc; 1989 Jun; 21(3):3468-70. PubMed ID: 2662490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
